Grifols SA (GRFS)
9.02
+0.38
(+4.40%)
USD |
NASDAQ |
Jan 21, 16:00
9.01
-0.01
(-0.11%)
After-Hours: 20:00
Grifols Total Liabilities (Quarterly): 14.46B for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| DBV Technologies SA | 57.64M |
| Autolus Therapeutics Plc | 396.50M |
| Mereo BioPharma Group Plc | 7.004M |
| Evaxion AS | 14.90M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 23.33B |
| Shareholders Equity (Quarterly) | 6.085B |
| Debt to Equity Ratio | 1.871 |
| Current Ratio | 2.482 |
| Net Debt Paydown Yield | 0.06% |